From: Analyzing COVID-19 progression with Markov multistage models: insights from a Korean cohort
Transition | Baseline transition rate | Hypertension (HR) | Diabetes (HR) |
---|---|---|---|
State 1–State 1 |  − 0.166 (− 0.18, − 0.153) |  |  |
State 1–State 2 | 0.166 (0.153,0.18) | 1.142 (0.961,1.357) | 0.98 (0.794,1.21) |
State 1–State 5 | 1.66e−05 (4.124 e−09,0.067) | 0.664 (6.452e−09,6.832e07) | 0.803 (1.036e−10,6.223e09) |
State 2–State 1 | 0.046 (0.044,0.049) | 1.229 (1.062,1.423) | 1.162 (0.966,1.398) |
State 2–State 2 |  − 0.086 (− 0.09, − 0.082) |  |  |
State 2–State 3 | 0.04 (0.037,0.042) | 1.676 (1.445,1.944) | 1.799 (1.518,2.131) |
State 2–State 5 | 3.234e−05 (1.921e−06, 5.444e−04) | 0.227 (4.941e−05,1.045e+03 | 0.4431 (1.427e−05,1.376e+04) |
State 3–State 2 | 0.195 (0.18, 0.212) | 1.038 (0.875,1.23) | 0.9553 (0.783,1.165) |
State 3–State 3 |  − 0.208 (− 0.225, − 0.192) |  |  |
State 3–State 4 | 0.001 (0.008, 0.017) | 1.6 (0.881,2.909) | 1.8989 (1.023,3.525) |
State 3–State 5 | 7.829e−05 (4.422e−07, 0.013) | 2.132 (0.222,2.049e+01) | 84.999 (1.882e−01, 3.838e+04) |
State 4–State 3 | 0.223 (0.143, 0.349) | 0.722 (0.324,1.609) | 1.717 (0.745,3.955) |
State 4–State 4 |  − 0.227 (− 0.354, − 0.144) |  |  |
State 4–State 5 | 2.865e−03 (2.396e−05, 0.342) | 10.4755 (1.224e−02,8.968e+03) | 0.26 (8.642e−05, 7.839e+02) |